MAPT and Alzheimer disease: Another 3D microfluidic AD model encompassing neurons, astrocytes, and microglia was recently developed by Park et al. This new platform exhibited most of AD's key characteristics, including p-tau accumulation, aggregation, and neuroinflammatory activity such as microglia recruitment and neurotoxic activity (including axonal cleavage) [109].